Regional variations uncovered in the impact of dexamethasone treatment for severe COVID-19

There may be important regional differences in the response to higher doses of steroids (dexamethasone) for patients with severe COVID-19, according to a recent sub-study of the COVID-STEROID 2 trial.

Leave A Comment

Your email address will not be published. Required fields are marked *